Medifast, Inc. faces declining demand amid GLP-1 impact, struggling repositioning efforts, and earnings uncertainty. Read ...

Gallagher Re, a reinsurance brokerage and risk management services provider, has released a report on the impact of GLP-1 ...

The long-standing question of how animals came to have an anus may have been solved by studies of which genes are active ...

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

Losing weight is a common New Year’s resolution, and many people are now turning to advanced weight-loss medications like ...

Below is a roundup of payer-centric news headlines you may have missed during the month of March 2025. | In March, a health ...

Potential US tariffs on pharmaceuticals could set off a ripple effect that extends far beyond the immediate price hikes, as ...

Food companies’ snack offerings are suffering as economic pressures combine with demand for healthier options.

You might have heard of love bombing as a dating red flag to watch out for. But did you know love bombing in friendship is a ...

The establishment of Hua Medicine’s pharmaceutical sales and marketing team resulted in significant sales growth in the first two months of 2025, opening a new model of innovative drug ...

There’s no question about the popularity of GLP-1 weight loss drugs like Ozempic and Wegovy, but some doctors are worried the ...

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.